Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption
Cancer Cell - United States
doi 10.1016/j.ccr.2013.12.010
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Elsevier BV